Skip to main content
. Author manuscript; available in PMC: 2011 Mar 8.
Published in final edited form as: Clin Exp Metastasis. 2008 Jun 6;25(6):601–610. doi: 10.1007/s10585-008-9183-1

Fig. 1.

Fig. 1

ARCaP EMT model in which selected growth factors or bone microenvironment drives ARCaPE cells to undergo mesenchymal-like transition to ARCaPM. Upon this morphologic transition (a), ARCaPM cells expressed both classic EMT markers (decreased expression of E-cadherin and cytokeratins 18/19 and increased expression of vimentin and N-cadherin) and novel markers (increased expression of RANKL and IL13Rα2) as analyzed by RT-PCR (b), western blot (c) and IHC (d)